The present study explores the efficacy of limonene, a cyclic terpene found in the rind of citrus fruits, for antibiofilm potential against species of the genus Streptococcus, which have been deeply studied worldwide owing to their multiple pathogenic efficacy. Limonene showed a concentration-dependent reduction in the biofilm formation of Streptococcus pyogenes (SF370), with minimal biofilm inhibitory concentration (MBIC) of 400 mg ml
INTRODUCTION
The genus Streptococcus, comprising a heterogeneous group of micro-organisms, holds outstanding importance in research due to the wide range of infections caused by these organisms. They mainly target the oral cavity, respiratory tract, blood stream and skin for mainly colonization (Jenkinson & Lamont, 1997) . The organisms mainly concentrated in this study were Streptococcus pyogenes and Streptococcus mutans, which are clinically important candidates in the genus, among which former is responsible for throat and skin infections, and the later for dental caries, (Matsui & Cvitkovitch, 2010; Patenge et al., 2013) .
A sessile, aggregate growth pattern of micro-organisms is commonly considered as biofilm (Bjarnsholt, 2013) . These biofilms account for over 80 % of microbial infections in the human body (Davies, 2003) . Biofilm-forming microbes show an innate resistance to antibiotics, disinfectants, and response to host cells (Nithya et al., 2011) , which in turn helps their persistence in chronic infections (Hoffman et al., 2005) .
Streptococcus pyogenes is an uncompromising exclusive human pathogen which targets the upper respiratory tract as its main portal of entry. Being equipped with various virulence factors such as M protein (Bisno, 1991) , lipoteichoic acid, encapsulation with hyaluronic acid (Crater et al., 1995) and secretion of exotoxins (streptolysin O, streptolysin S, hyaluronidase and streptokinase), the pathogen is at the helm of over 600 million infections a year (Lynskey et al., 2011) , ranging from self-limiting pharyngitis to life-threatening streptococcal toxic shock syndrome (Cunningham, 2000) .
On the other hand, Streptococcus mutans, an acidogenic organism, is a key player in dental caries, a multifactorial disorder. It is the first organism to attack infants as the first teeth appear (Matsui & Cvitkovitch, 2010) . Its acidogenic and aciduric nature and its glucan-synthesizing ability are the key virulence properties (D'Angelis et al., 2012) of the organism, which aid its anchoring to the tooth surface, internalization and tooth decay.
Limonene [1-methyl-4-(1-methylethenyl) cyclohexane], a monocyclic monoterpene, is found in the rind of citrus fruits. Ideally, orange juice possesses 100 p.p.m. of limonene (Sun, 2007) . D-Limonene is listed as generally recognized as safe in the Code of Federal Regulation (USA) for a flavouring agent. It is considered as an excellent solvent for cholesterol and is used clinically to dissolve cholesterol in gall stones (Igimi et al., 1976) . Limonene is clinically proven to be effective in the treatment of chronic heartburn or gastro-oesophageal reflux disorder (Wilkins, 2002) . Limonene was also found to possess anticancer activity against chemically induced carcinomas in rodents, when fed orally. Time of appearance of first tumour was extended by feeding limonene at the initiation stage (Elson et al., 1988) .
The current study explored the antibiofilm potential of limonene against species of the genus Streptococcus. Its influence on the virulence of the organisms and plausible mechanism of the antibiofilm activity were unveiled with a surface-coating assay and physiological assays. The results were validated through real-time PCR.
METHODS
Ethics statement. In the current study, healthy human blood was used only for research purposes. The blood sample used in the study was taken by technically trained persons. The use of the sample and experimental methodology were assessed and approved by the Institutional Ethical Committee under the no. IEC/AU/2014/3.
Bacterial strains and growth conditions. Streptococcus pyogenes SF370, five clinical isolates of Streptococcus pyogenes belonging to different emm types [M56 (GenBank accession no. EU636227), M65 (EU660377), M74 (EU660380), M100 (EU660379) and st38 (EU636229)] (Thenmozhi et al., 2011) , Streptococcus mutans UA159 and Streptococcus mitis ATCC 6249 were the organisms used in the study. Tryptose agar (Himedia) supplemented with 5 % defibrinated sheep blood or ToddHewitt broth supplemented with 5 % yeast extract and 5 % glucose (THYG; Himedia) were the media used for routine culturing of Streptococcus pyogenes. Tryptose agar (Himedia) or tryptic soy broth supplemented with 1 % sucrose (TSBS; Himedia) was used for culturing Streptococcus mutans and Streptococcus mitis. The culture-inoculated tubes and plates were sealed and incubated at 37 uC under static conditions.
Determination of minimum biofilm inhibitory concentration (MBIC). MBIC was identified in a 24-well plate by a micro-dilution method. Biofilm-forming Streptococcus pyogenes SF370 was treated with increasing concentrations (from 50 to 500 mg ml
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) of limonene in a 24-well plate with 1 ml THYG broth. One per cent of overnight culture (*2|10 3 cells) was used as inoculum. The plates were incubated for 24 h at 37 uC and read spectrophotometrically at 600 nm, so as to evaluate the changes in cell density. All the wells (control and limonene-treated) were washed in a similar fashion. After discarding the planktonic cells, the wells were washed three times with sterile distilled water and allowed to air-dry. The wells were then stained with 0.4 % crystal violet and incubated at room temperature (28 uC) for 10 min. The unbound crystal violet was then washed away with distilled water and the plates were allowed to air-dry. Biofilm-bound crystal violet was extracted with 20 % (v/v) glacial acetic acid solution. The wells were then read at 570 nm for biofilm quantification. MBIC was determined as the minimal concentration in which a minimum of 80 % of bacterial biofilm inhibition was observed.
Growth curve analysis. An ideal antibiofilm agent should not impose any growth inhibitory effect on the pathogen. Hence the dynamics of bacterial growth in the presence of limonene was monitored every 1 h over a period of 24 h for all strains (five clinical isolates of Streptococcus pyogenes, reference strain Streptococcus pyogenes SF370, Streptococcus mutans UA159 and Streptococcus mitis ATCC 6249). Limonene at increasing concentration (200-800 mg ml 21 ) was added individually to 50 ml THYG, to which 1 % inoculum from overnight culture was introduced. DMSO, which was used to dissolve limonene, was employed as a vehicle control and medium containing limonene without inoculum was employed as a blank. Flasks were incubated at 37 uC and the OD at 600 nm was recorded at every 1 h interval up to 24 h.
Analysis of antibiofilm potential of limonene. Since clinical isolates are better biofilm formers (Conley et al., 2003; Baldassarri et al., 2006; Roberts et al., 2012) , the antibiofilm potential of limonene at MBIC (400 mg ml 21 ) was tested against five clinical isolates belonging to different M serotypes of Streptococcus pyogenes in a 24-well plate as described above. Further, to evaluate if limonene has antibiofilm potential, the biofilm inhibition was assessed against Streptococcus mutans and Streptococcus mitis.
Cell viability assay. Influence of limonene on cell viability of the organisms was assessed using XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide)-menadione as described by Bandara et al. (2010) . Briefly, equal numbers of cells (*2.0|10 3 c.f.u.) were used to inoculate 1 ml of medium with and without limonene (400 mg ml 21 ) and allowed to grow for 24 h at 37 uC. The cultures were then harvested, washed twice with PBS (pH 7.4) and resuspended in 200 ml of the same. To this cell suspension, 25 ml XTT-menadione substrate was added, and cells were incubated in the dark at room temperature (28 uC) for 6 h. XTTmenadione substrate was prepared by mixing 12.5 ml Solution I (2 mg XTT dissolved in 10 ml PBS) and 1 ml Solution II (1.72 mg menadione sulfate dissolved in 10 ml acetone). Cell viability is directly proportional to reduction of XTT into orange-coloured, water-soluble formazan, which was quantified spectrophotometrically at 490 nm.
Microscopic techniques. To get an insight into the effect of limonene on the biofilm architecture, microscopic analysis was performed. For microscopic visualization, the biofilms of Streptococcus pyogenes (SF370 and clinical isolates), Streptococcus mutans and Streptococcus mitis were allowed to grow on glass pieces (1|1 cm) placed in 24-well polystyrene plates with THYG and TSBS media supplemented with and without limonene (400 mg ml
). The plates were incubated for 24 h at 37 uC. The glass pieces were then washed with sterile PBS and processed accordingly.
Light microscopy. The slides washed with sterile PBS were stained with 0.4 % crystal violet for 10 min and allowed to air-dry. The stained glass pieces were placed on a microscope slide, such that the biofilms were directed upwards, and inspected with a light microscope at |400 magnification.
Scanning electron microscopy (SEM). The biofilms on the glass pieces were fixed as described by Thenmozhi et al. (2011) with slight modifications. Briefly, the slides were fixed with 2 % glutaraldehyde in PBS for 8 h at 4 uC. The slides were subsequently washed in PBS and dehydrated with ethanol by gradually increasing its percentage (v/v) (20, 50, 70, 90 and 100 % for 3 min each). After treatment with 100 % ethanol, the slides were air-dried at room temperature (28 uC). Gold sputtering was done on the slides prior to observation under a scanning electron microscope (VEGA 3 TESCAN, Czech Republic).
Surface-coating assay. To check whether a limonene-coated surface inhibits biofilm formation, a surface-coating assay was performed as described by Karwacki et al. (2013) with slight modification. Briefly, limonene was coated over glass, stainless steel and titanium pieces (1|1 cm) and allowed to dry. Surfaces swabbed with vehicle (DMSO) served as a vehicle control. The dried pieces were then placed in 24-well plates containing 1 ml of THYG or TSBS broth and 1 % inoculum of overnight culture of Streptococcus pyogenes or Streptococcus mutans and incubated at 37 uC for 24 h. The slides were stained with fluorescent acridine orange dye (0.1 %, w/v) for 1 min, rinsed with PBS and air-dried. The pieces were observed under a confocal laser scanning microscope using a 500-640 nm band pass emission filter with 488 nm argon laser for excitation of the stain. Inhibition of biofilm on limonene-swabbed pieces indicated the inability of the organism to form a biofilm.
Assays for Streptococcus pyogenes

Blood survival assay
The viability of Streptococcus pyogenes in healthy human blood is predominantly determined by M protein, a surface-associated protein that helps to evade phagocytosis (Courtney et al., 2006) . The effect of limonene on M protein was assessed using a blood survival assay (Zutkis et al., 2014) . Briefly, limonene-treated and untreated Streptococcus pyogenes were allowed to grow overnight. Fifty microlitres of this overnight culture was added to 450 ml of healthy human blood and mixed thoroughly. The mixtures were rotated for 3 h at 37 uC. The viability of cells in control and treated samples were quantified by the spread-plate method on tryptose agar plates.
Protease quantification assay
SpeB (streptococcal pyrogenic exotoxin B) is the predominant extracellular protease produced by all Group A streptococci. It plays an important role in soft tissue pathologies by facilitating tissue invasion (Collin & Olsén, 2003) . Extracellular cysteine protease production by Streptococcus pyogenes upon limonene treatment was quantified as described by Hollands et al. (2008) . Briefly, Streptococcus pyogenes was allowed to grow for 24 h at 37 uC in THYG in the presence and absence of limonene (400 mg ml 21 ). The cultures were then harvested and the supernatants were filter-sterilized through 0.2 mm syringe filters. Cell-free culture supernatant was mixed with 200 ml of activation buffer (1 mM EDTA, 20 mM DTT in 0.1 M sodium acetate buffer, pH 5.0) and incubated for 30 min at 40 uC. DTT, a reducing agent in the activation buffer, activates protease by facilitating autocatalysis (Hytönen et al., 2001) . Four-hundred microlitres of 2 % azocasein was then added to the incubated mixture and further incubated for 1 h at 40 uC. Trichloroacetic acid (to a final concentration of 10 %, w/v) was added to stop the reaction by precipitating the proteins. The mixture was then centrifuged at 10000 g and the absorbance of the supernatant was read at 366 nm.
Assays for Streptococcus mutans
Terminal pH determination
Streptococcus mutans is acidogenic in nature, i.e. it produces lactic acid by metabolizing glucose. The acid production favours tooth enamel corrosion leading to plaque formation. The effect of limonene on acid production of Streptococcus mutans was assessed as reported earlier by Korithoski et al. (2007) with slight modification. Three millilitres of TSBS with limonene (200 mg ml 21 or 400 mg ml 21 ) or the vehicle control (DMSO) was inoculated with 1 % of overnight culture of Streptococcus mutans and incubated at 37 uC for 24 h. The pH of the bacterial broth was determined at the onset and after 24 h of incubation. The change in pH was recorded.
Glycolytic pH drop assay
The effect of limonene on the acidogenic property of Streptococcus mutans was further evaluated using the glycolytic pH drop assay as described by Ban et al. (2012) . The cells of Streptococcus mutans from the suspension cultures were centrifuged at 15000 g and, washed once with salt solution (50 mM KCl and 1 mM MgCl 2 ) and resuspended in the same along with limonene (200 and 400 mg ml 21 ) or vehicle control (DMSO). The pH was adjusted to pH 7.2 with 0.2 M KOH solution. Glucose was then added to obtain a final concentration of 1 % (w/v). The pH of the mixture was assessed over a period of 60 min.
Total RNA isolation and cDNA synthesis
The effect of limonene on the expression of important receptors and virulence factors of Streptococcus pyogenes and Streptococcus mutans was assessed. For this, total RNA was isolated from Streptococcus pyogenes SF370 and Streptococcus mutans UA159 individually, at mid exponential phase, in the presence and absence of limonene at MBIC using Trizol reagent and diethylpyrocarbonate (DEPC)-treated water. The first-strand cDNAs were synthesized using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems).
Real-time PCR (qPCR) analysis
Real-time PCR was performed with gene-specific primers of Streptococcus pyogenes (covR, covS, srv, mga, speB, luxS and gyr) and Streptococcus mutans (comDE, gbpB, smu0630, vicR and 16S). The primers were combined individually with the PCR mix (SYBR Green kit, Applied Biosystems) at a predefined ratio. Housekeeping genes, gyrase (gyr) for Streptococcus pyogenes and 16S rRNA for Streptococcus mutans, were taken as internal controls. The PCR cycle for Streptococcus pyogenes included an initial denaturation at 94 uC for 5 min, followed by a 30-cycle amplification consisting of denaturation at 94 uC for 45 s, annealing at 58.5 uC for 45 s and extension at 72 uC for 30 s, and a final extension at 72 uC for 10 min, and that for Streptococcus mutans included an initial denaturation at 94 uC for 5 min, followed by a 30-cycle amplification consisting of denaturation at 94 uC for 1 min, annealing at 60 uC for 1 min and extension at 72 uC for 1 min, and a final extension at 72 uC for 10 min. The steady-state levels of candidate genes were assessed from the cycle threshold (C t ) values of the candidate genes relative to the C t values of corresponding endogenous controls.
RESULTS AND DISCUSSION
Even though various plant extracts (Limsuwan et al., 2012) , coral-associated actinomycete isolates (Nithyanand et al., 2010) , marine microbial isolates (Thenmozhi et al., 2009; Gowrishankar et al., 2014) and compounds like morin hydrate (Green et al., 2012) have already been reported for antibiofilm activity against species of the genus Streptococcus, the need for novel antibiofilm agents is still high. Limonene, a non-toxic, cyclic monoterpene, has myriad clinical applications such as gall stone dissolution, heartburn relief and anti-cancer activity (Sun, 2007) . A number of studies have reported the antibacterial (Selim et al., 2014; Chen et al., 2015) , antifungal (Singh et al., 2010; Chen et al., 2013) and antibiofilm activity (Schillaci et al., 2008; Budzyń ska? et al., 2011; Adukwu et al., 2012) of essential oils of various plants and seeds containing limonene as one of its ingredients. On the other hand, only few studies have explored the antimicrobial activity of pure limonene (Chee et al., 2009; Jaroenkit et al., 2011) . Chee et al. (2009) showed 0.5 % (v/v) limonene as MIC against Trichophyton rubrum. The study by Jaroenkit et al. (2011) showed that D-limonene exerts a bacteriostatic effect against Pseudomonas spp. (0.7 %, v/v), Klebsiella spp. (0.9 %, v/v) and Staphylococcus aureus (0.9 %, v/v). However, to the best of our knowledge, pure limonene has not been reported for its antibiofilm activity. Hence, in the present study, an attempt was made to study the antibiofilm and anti-infective efficacy of limonene and its plausible mode of action against species of the genus Streptococcus.
Determination of MBIC and antibiofilm efficacy of limonene
A biofilm inhibition assay was performed with increasing concentrations of limonene against Streptococcus pyogenes SF370 in order to determine MBIC. The minimum concentration of the compound which exhibited at least 80 % of biofilm inhibition was considered as MBIC. Crystal-violetstained biofilm biomass was quantified by measuring OD at 570 nm. The results unveiled a concentration-dependent increase in antibiofilm activity of limonene with significant reduction observed at concentrations above 350 mg ml
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. The concentration (400 mg ml
) which showed 83 % inhibition was considered as MBIC (Fig. 1) . Since clinical isolates are more potent in biofilm formation (Conley et al., 2003; Baldassarri et al., 2006; Roberts et al., 2012) , the biofilm antagonistic activity of limonene at 400 mg ml 21 was evaluated against five clinical isolates of Streptococcus pyogenes. Limonene showed a remarkable antibiofilm activity (75-95 %) against all the clinical isolates tested at 400 mg ml
. To delineate the antibiofilm efficacy of limonene against other species of the genus Streptococcus, its effect on the biofilm formation of Streptococcus mutans and Streptococcus mitis was also assessed. It was evident from the results that limonene indeed possesses a broad-spectrum antibiofilm activity against different species of Streptococcus (Fig. 2) .
Limonene exhibits non-bactericidal antibiofilm activity
One of the important constraints for an ideal antibiofilm agent is not interfering with the basic metabolic activity ) on Streptococcus pyogenes (reference strain -SF370; clinical isolates -M56, M65, M74, st38), S. mutans (reference strain -UA159) and S. mitis (reference strain -ATCC 6249). A minimum of 75 % biofilm inhibition was observed against Streptococcus mutans and Streptococcus mitis, and maximum activity was seen against strain st38. Data presented are mean¡SD. Antibiofilm activity of limonene of the organism. The interference of the agent in metabolic activity would provoke the organism to develop antibiotic resistance. The growth pattern of all the strains was tested with increasing concentrations of limonene. Even though extended lag phase was observed in most of the strains tested, at the end of 24 h, limonene was found to exhibit no antibacterial activity against all the strains tested at 400 mg ml 21 . However, when the concentration was increased, limonene showed mild antibacterial activity against most of the strains tested except st38, SF370 and Streptococcus mutans (Fig. 3) . The difference in cell viability was also assessed with the help of XTT, which gets reduced into a water-soluble, orange-coloured product when acted upon by the active enzymes in live cells. Hence, development of orange colour, which is read at 475 nm, is directly proportional to cell viability. The result revealed that 400 mg limonene ml 21 does not influence the metabolic activity of either Streptococcus pyogenes or Streptococcus mutans (Fig. 4) . This property of limonene brings it one step closer to being an ideal antibiofilm agent.
Limonene affects micro-colony formation and biofilm architecture
The nature and architecture of biofilms play a crucial role in preventing the penetration of therapeutic antibiotics, thereby avoiding their contact with microbial cells (Schuster & Markx, 2014) . Microscopic studies were done to study limonene-induced changes in biofilm architecture and to discern the stage at which limonene inhibits biofilm formation. The light-microscopic images of 24-hour-old limonene-treated microbial biofilms showed far fewer micro-colonies compared with the corresponding control, suggesting that limonene interferes with biofilm formation between the micro-colony formation and irreversible binding stages of biofilm formation (Fig. 5a ). This interruption of biofilm formation by limonene successively led to the decrease in surface area covered by streptococcal biofilm in the presence of limonene.
In order to get a deep insight into the morphological changes upon treatment, biofilms were viewed by SEM (approx. |16 000). The result depicted decreased cell clusters in treated samples (Fig. 5b) . Cell envelopes of control Streptococcus pyogenes cultures were found to be intact with a clear cell boundary, whereas treated samples showed an increased extracellular matrix, disturbed cell envelope and chunks of the envelope around the cells. Mutational studies carried out by Dalton & Scott (2004) showed that mutation in the covS gene of Streptococcus pyogenes resulted in mucoidal colonies. This report correlates with the present study wherein the covS gene was found to be downregulated in limonene-treated Streptococcus pyogenes (Fig. 6) . Hence, the downregulation of the covS gene is postulated to be the reason for the increase in extracellular matrix secretion. In the case of Streptococcus mutans, an abnormal extracellular coating was seen over the cells. This result is well in line with vicRK mutational studies by Senadheera et al. (2005) , wherein they predicted this abnormal extracellular coating to be carbohydrate polymers deposited over cell surfaces. On the other hand, Stipp et al. (2013) explained the crucial role of covR and vicRK in regulation of genes involved in cell surface biogenesis. Since the gene expression analysis of Streptococcus mutans in the current study also showed downregulation of vicR, the variations in the Streptococcus mutans cell surface are likely due to downregulation of the vicR gene.
Limonene-coated surface inhibits biofilm formation
Since limonene is oily in nature, it was hypothesized that it may modify the surface, making it unsuitable for microbes to form biofilm. A surface-coating assay was performed which showed the inability of both pathogens to form biofilm on a limonene-coated surface, confirming that limonene indeed makes the surface unsuitable for biofilm formation (Fig. 7) . Considering dental implants, the majority of which are made of titanium (the most preferred inert metal) (Chaturvedi, 2013) and stainless steel, the inability of Streptococcus mutans to form biofilm over surfaces coated with limonene gives an edge for limonene to be used clinically against Streptococcus mutans. Similar activity has already been reported by Karwacki et al. (2013), wherein Staphylococcus aureus failed to form biofilm over a surface coated with a capsular polysaccharide isolated from Actinobacillus pleuropneumoniae serotype 5.
Since limonene shows surface-oriented antibiofilm activity, the influence of limonene on the extracellular phenomenon of the organisms was studied.
Effect of limonene on M protein and protease of Streptococcus pyogenes
M protein, a surface-associated protein of Streptococcus pyogenes plays a key role in its adhesion and anti-phagocytic nature (Fischetti, 1989) . The influence of limonene on surface-associated M protein of Streptococcus pyogenes was assessed by investigating the viability of control and treated Streptococcus pyogenes in healthy human blood. A decrease in M protein will be reflected by a decrease in the total number of viable cells. The total number of c.f.u. in the limonene-treated sample was found to be much less compared with the control, manifesting that limonene depletes the anti-phagocytic efficacy of surface-associated M protein (Fig. 8a) .
The extracellular cysteine protease encoded by speB in Streptococcus pyogenes is known for its contribution in soft tissue pathologies like necrotizing fasciitis. Hence, it is important to study the effect of limonene on protease production. The results showed an insignificant increase in protease production in treated cells compared with untreated controls (Fig. 8b) . A possible reason for this trivial increase in protease production could be due to stress created by limonene on Streptococcus pyogenes. The results of the blood survival assay and protease quantification go in parallel with the gene expression studies in which the mga gene was downregulated. mga is a multiple gene regulator that activates the expression of several virulence genes of S. pyogenes including the emm gene which encodes M protein (Cunningham, 2000) . Hence, downregulation of mga is expected to reduce the expression of M protein. On the other hand, Kansal et al. (2000) observed an inverse correlation between speB production and intact M protein production. In addition, their study revealed that inhibition of cysteine protease (SpeB) activity blocked the cleavage of the surface M protein. Hence, we speculate that the observed decrease in M protein could be due to the combined effect of decreased mga and moderately increased speB gene (which is responsible for protease production) expression (Fig. 6) .
Limonene deters the aciduric nature of Streptococcus mutans
One of the major cariogenic factors associated with Streptococcus mutans is its acidogenicity, the ability to produce acid (Matsui & Cvitkovitch, 2010) . In order to study the effect of limonene on the acidogenic property of Streptococcus mutans, terminal pH determination was performed. Limonene at 200 mg ml 21 and 400 mg ml 21 showed significant inhibition of acid production. Streptococcus mutans in the presence of 400 mg limonene ml 21 for 24 h showed pH of about 5.3, whereas that of its control was recorded to be pH 4.3 (Table 1 ). This result was comparable with the previous work done by Hasan et al. (2012) in which the pH of Streptococcus mutans grown in the presence of 625 mg ml 21 ethanolic extract of Emblica officinalis was reported to be about pH 5.78 after 18 h.
The anti-acidogenic property of limonene against Streptococcus mutans was further affirmed by using a glycolytic pH drop assay. The result confirmed the reduced efficacy of Streptococcus mutans in terms of acid production from glucose, on treatment with limonene. Limonene showed 100 % inhibition at 400 mg ml 21 (Table 1) . In comparison, extracts of Dorstenia asaroides showed about 90 % inhibition of acid production at 12.5 mg ml 21 (D'Angelis et al., 2012). Together, the results of terminal pH determination and the glycolytic pH drop assay confirm the anti-acidogenic property of limonene, making it a strong anti-cariogenic agent against Streptococcus mutans.
The results of the surface-coating assay corroborate a previous study by Wilkins (2002) where the author has recorded that limonene neutralizes the effect of gastric acid by coating the wall. However, the result of glycolytic pH drop assay observed in the current study gives a new dimension that in addition to merely coating the walls and preventing the contact of acid with the mucosal linings, limonene also possesses a discrete mechanism for acid neutralization, the combined effect of which is expected to result in acid neutralization in the gastrointestinal tract.
Impact of limonene on virulence gene expression
To elucidate the molecular mechanism by which limonene inhibits streptococcal biofilms, gene expression studies were done on candidate regulator genes involved in biofilm formation and virulence (Table 2) . With regard to Streptococcus pyogenes, real-time analysis showed a perceptible upregulation of the covR gene (53 %) on limonene treatment. On the other hand, the covS and mga genes were found to be downregulated by 26 % and 57 % respectively. speB showed slight upregulation by 16 %. srv and luxS showed no significant difference in their expression levels (Fig. 6 ).
covR is a repressor gene (Malke & Ferretti. 2007 ) involved in the covRS two-component system pathway. It plays an important role in the suppression of virulence genes using promoter occlusion as the primary mechanism. Normally, covR is controlled by its cognate sensor kinase covS. Nevertheless, under stress conditions, covR acts independently (Dalton et al., 2006) . In the current scenario, it is hypothesized that treatment of Streptococcus pyogenes with limonene has mimicked stress conditions and hence, in spite of covS downregulation, covR is found to be upregulated. Roberts & Scott (2007) have proved that covR has a negative influence on mga by regulating rivR (a RALP family regulator which enhances transcription of the mga gene). A similar phenomenon was observed in the present study where covR was upregulated and mga was downregulated. Mga is a stand-alone DNA-binding protein that activates the expression of virulence genes encoding molecules which are important for colonization and immune evasion, such as the M protein family (emm, mrp and enn), C5a peptidase (scpA) and collagen-like protein 1 (scl1). mgadefective mutants were found to be more sensitive to phagocytosis and have decreased adherence capability (Patenge et al., 2013) . This is in parallel with the present study in which mga downregulation together with decrease in survival of Streptococcus pyogenes on healthy human blood was observed. Since scl1 (collagen-like protein) comes directly under the control of the mga gene, downregulation of the mga gene is expected to decrease scl1 gene expression. Ribardo et al. (2004) reported that scl1 mutants lack biofilm-forming efficacy. Hence, the observed defect in biofilm formation upon limonene treatment could be attributed to indirect influence of limonene over scl1 via mga. Cho & Caparon (2005) also reported that mga mutants of Streptococcus pyogenes are unable to form biofilms.
luxS is another candidate gene that plays a crucial role in early stages of streptococcal biofilm formation (Patenge et al., 2013) . However luxS expression was unaltered in limonene-treated and untreated cells, further confirming our notion that biofilm inhibition by limonene is mediated through the mga gene rather than via luxS. Influence of limonene was also studied on the srv gene, a streptococcal virulence regulator which is also essential for biofilm formation (Doern et al., 2009) . Expression level of the srv gene is inversely proportional to that of speB. speB encodes a cysteine protease, which degrades the proteins involved in streptococcal biofilm. Doern et al. (2009) have stated that, under normal conditions, extracellular speB is completely absent in 24 h biofilm while in srv mutant cells (which are impaired in biofilm formation), a detectable amount of speB is found. Hence, the slight upregulation of speB observed in the present study could also be the reason for biofilm inhibition. The increase in speB expression was also validated by protease quantification (Fig. 8b) and the same could be the reason for the chunks found around cells in the SEM image (Fig. 5b) .
In Streptococcus mutans, influence of limonene on four important genes which are directly or indirectly involved in biofilm formation, such as gbpB (glucan binding protein), vicR (two-component regulatory system which regulates surface associated genes), comDE (important regulatory gene in quorum sensing cascade) and smu630 (hypothetical protein involved in biofilm formation), was assessed. Limonene was found to inhibit all four genes by about 80 % (Fig. 6 ).
To sum up, the present study reports on the antibiofilm efficacy of limonene against Streptococcus pyogenes, Streptococcus mutans and Streptococcus mitis. The results of the surface-coating assay and differential regulation of genes involved in regulation of cell surface proteins (mga, covR) in Streptococcus pyogenes and vicR of Streptococcus mutans substantiates our notion of limonene possessing surfacetargeted antibiofilm activity. The inability of Streptococcus mutans to form biofilm on the limonene-coated surface of dental implants makes it a strong candidate for use as a therapeutic agent against dental decay. An endeavour in the proteomic field is expected to throw more light on the mode of action and unveil other protein targets of limonene for its antibiofilm activity.
